Bisulfite Conversion of DNA from Tissues, Cell Lines, Buffy Coat, FFPE Tissues, Microdissected Cells, Swabs, Sputum, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Methods in molecular biology

• Publication date

  2015-07-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/7651_2015_260PMID 26138988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA Methylation Analysis of Free-Circulating DNA in Body Fluids.

  2018cited by this paper
• Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine

  2014cited by this paper
• Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions

  2013cited by this paper
• Cancer Development, Progression, and Therapy: An Epigenetic Overview

  2013cited by this paper
• Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition

  2013cited by this paper
• The conversion of protonated cytosine-SO3(-) to uracil-SO3(-): insights into the novel induced hydrolytic deamination through bisulfite catalysis.

  2013cited by this paper
• Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.

  2013cited by this paper
• Functions of DNA methylation and hydroxymethylation in mammalian development.

  2013cited by this paper
• Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine

  2013cited by this paper
• Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

  2013cited by this paper
• Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.

  2013cited by this paper
• SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma

  2011cited by this paper
• Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation.

  2010cited by this paper
• Bisulfite Sequencing of DNA

  2010cited by this paper
• Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.

  2010cited by this paper
• MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

  2010cited by this paper
• DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy.

  2009cited by this paper
• Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.

  2009cited by this paper
• Bisulfite modification for analysis of DNA methylation.

  2008cited by this paper
• Errors in the bisulfite conversion of DNA: modulating inappropriate- and failed-conversion frequencies

  2008cited by this paper
• Optimization of PCR amplification for B-and T-cell clonality analysis on formalin-fixed and paraffin-embedded samples

  2008cited by this paper
• The bisulfite genomic sequencing used in the analysis of epigenetic states, a technique in the emerging environmental genotoxicology research.

  2008cited by this paper
• Tissue preparation: Tissue issues

  2007cited by this paper
• Degradation of DNA by bisulfite treatment.

  2007cited by this paper
• Accelerated bisulfite-deamination of cytosine in the genomic sequencing procedure for DNA methylation analysis.

  2004cited by this paper
• High-speed conversion of cytosine to uracil in bisulfite genomic sequencing analysis of DNA methylation.

  2004cited by this paper
• Bisulfite conversion of genomic DNA for methylation analysis: protocol simplification with higher recovery applicable to limited samples and increased throughput.

  2004cited by this paper
• Methylation sequencing from limiting DNA: embryonic, fixed, and microdissected cells.

  2002cited by this paper
• Bisulfite genomic sequencing: systematic investigation of critical experimental parameters

  2001cited by this paper
• Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

  2000cited by this paper
• A bisulfite method of 5-methylcytosine mapping that minimizes template degradation.

  1995cited by this paper
• Efficiency of DNA-histone crosslinking induced by saturated and unsaturated aldehydes in vitro.

  1992cited by this paper
• A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

  1992cited by this paper

• CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma

  2023cites this paper
• Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing

  2022cites this paper
• Methylated p16 gene is associated with negative expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in breast cancer

  2021cites this paper
• Prognostische und prädiktive Methylierungsbiomarker für HNSCC

  2020cites this paper
• Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma

  2020cites this paper
• LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma

  2020cites this paper
• Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

  2020cites this paper
• DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature

  2019cites this paper
• Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases

  2018cites this paper
• Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis

  2018cites this paper
• 3 D NA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

  2017cites this paper
• Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory

  2017cites this paper
• PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

  2017cites this paper
• CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients

  2016cites this paper
• Current status and future perspectives of circulating cell-free DNA methylation in clinical diagnostics

  2016cites this paper
• DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract

  2016cites this paper
• Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites

  2016cites this paper
• SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas

  2016cites this paper